Kate Mulvany

Writer

Kate Mulvany is an award-winning playwright and screenwriter.

Kate’s play The Rasputin Affair has recently been produced at the Ensemble Theatre and her play Jasper Jones, an adaptation of Craig Silvey’s novel has enjoyed great success at Belvoir Street Theatre and the MTC, in two separate productions, after its Barking Gecko premiere in 2015. In 2015 Kate’s play Masquerade, a reimagining of the much-loved children’s book by Kit Williams, was performed at the 2015 Sydney Festival and the State Theatre Company of South Australia as well as Melbourne Festival, produced by Griffin Theatre Company. 

Her autobiographical play The Seed, (Belvoir Street Theatre) won the Sydney Theatre Award for Best Independent Production. With Kate performing in the play, it received great critical success and toured nationally and is currently being developed into a feature film. Kate's Medea, co-written with Anne-Louise Sarks, having been produced by Belvoir Street Theatre in 2012, won several awards including an AWGIE and five Sydney Theatre Awards, and has gone on to be produced in Poland and at the Gate Theatre in London, to rave reviews. Other plays and musicals include; The Danger Age, Blood and Bone, The Web, Somewhere (co-written with Tim Minchin for the Joan Sutherland PAC) and Storytime, which won Kate the 2004 Philip Parsons Award.

As a screenwriter, Kate has worked on the development of several television series for Australian production houses and she is developing a feature film based on The Seed and an untitled Matchbox Pictures 1 hour drama.

Kate is also an award-winning stage and screen actor with credits with many of the major Sydney theatre companies and in many television dramas and films. Most recently Kate has played the eponymous role in Richard III (Bell Shakespeare) to great critical and popular acclaim.

For enquiries regarding Kate Mulvany's writing, please contact us via email or on (02) 9319 7199. For all her acting enquiries, please contact Sharron Meissner at Meissner Management via email or on (02) 8005 5797